Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study
Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study
Enrolling by invitation · NCT04260269 · Registry updated 2024-12-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study | Solid Tumor | Enrolling by invitation | Not stated | 2024-12-12 | NCT04260269 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Helsinki University Central Hospital | 127 |
| Tampere University Hospital | 101 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Academic Medical Center | Amsterdam | Netherlands | 6 |
| Department of Oncology | Tampere | Finland | 1 |
| Haukeland University Hospital | Bergen | Norway | 52 |
| Helsinki University Central Hospital | Helsinki | Finland | 4 |
| Karolinska University Hospital | Stockholm | Sweden | 87 |
| Landspitali | Reykjavik | Iceland | 2 |
| Odense University Hospital | Odense | Denmark | 57 |
| Oulu University Hospital | Oulu | Finland | 44 |
| Skone university hospital | Lund | Sweden | 1 |
| St. Vincents University Hospital | Dublin | Ireland | 1 |
| Sundsvall Hospital | Sundsvall | Sweden | 8 |
| Turku University Hospital | Turku | Finland | 61 |
| Uppsala Academic Hospital | Uppsala | Sweden | 3 |